SMO and skin basal cell carcinoma: Therefore, SMO inhibitors, such as vismodegib and sonidegib, have allowed a revolution in the treatment of advanced BCC, thus, offering a successful therapeutic option for disfiguring and life-threatening disease associated with a long-term clinical benefit.